Regeneron Pharmaceuticals is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines, including EYLEA and EYLEA HD for ophthalmology, Dupixent in immunology (co-developed with Sanofi), Libtayo and Lynozyfic in oncology and hematology, and Praluent for cardiovascular disease. - View it on GitHub